{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:20:39Z","timestamp":1785806439105,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stomatology, Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jormas.2022.03.012","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T13:48:22Z","timestamp":1647438502000},"page":"e458-e463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Possible association of methotrexate use with osteonecrosis of the jaw: Systematic review"],"prefix":"10.1016","volume":"123","author":[{"given":"Marko","family":"Milosavljevi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0006-2290","authenticated-orcid":false,"given":"Milica","family":"Jovanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Foli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo\u0161","family":"\u017divi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Zdravkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Veli\u010dkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slobodan","family":"Jankovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jormas.2022.03.012_bib0001","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1016\/j.oooo.2017.09.005","article-title":"Methotrexate-associated osteonecrosis of the jaw: a report of two cases","volume":"124","author":"Henien","year":"2017","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"4","key":"10.1016\/j.jormas.2022.03.012_bib0002","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2169\/internalmedicine.8946-17","article-title":"Oral methotrexate-related lymphoproliferative disease presenting with severe osteonecrosis of the jaw: a case report and literature review","volume":"58","author":"Furukawa","year":"2018","journal-title":"Intern Med Tokyo Jpn"},{"issue":"2","key":"10.1016\/j.jormas.2022.03.012_bib0003","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.joms.2020.08.011","article-title":"Rare oral presentation of a mycophenolate mofetil-related other iatrogenic immunodeficiency-associated lymphoproliferative disorder (MMF-OIA-LPD) lesion: a case report and literature review","volume":"79","author":"Taliaferro","year":"2021","journal-title":"J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.jormas.2022.03.012_bib0004","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.bdj.4811972","article-title":"Methotrexate and oral ulceration","volume":"198","author":"Deeming","year":"2005","journal-title":"Br Dent J"},{"issue":"1","key":"10.1016\/j.jormas.2022.03.012_bib0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.joms.2017.05.027","article-title":"Methotrexate-related lymphoproliferative disorder in patients with osteonecrosis of the jaw: a 3-case report and literature review","volume":"76","author":"Furudate","year":"2018","journal-title":"J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg"},{"issue":"7","key":"10.1016\/j.jormas.2022.03.012_bib0006","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1111\/bcp.14681","article-title":"Medication-related osteonecrosis of the jaw: analysing the range of implicated drugs from the Australian database of adverse event notifications","volume":"87","author":"Teoh","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jormas.2022.03.012_bib0007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jormas.2022.03.012_bib0008","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.4317\/medoral.23191","article-title":"Review and update on drugs related to the development of osteonecrosis of the jaw","volume":"25","author":"Eguia","year":"2020","journal-title":"Med Oral Patol Oral Cirugia Bucal"},{"issue":"1","key":"10.1016\/j.jormas.2022.03.012_bib0009","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/jiaomr.jiaomr_206_19","article-title":"Medication-related osteonecrosis of the jaw: a review about etiology, risk factors, pathophysiology, and treatment","volume":"32","author":"Singar","year":"2020","journal-title":"J Indian Acad Oral Med Radiol"},{"issue":"2","key":"10.1016\/j.jormas.2022.03.012_bib0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10006-018-0688-8","article-title":"Low-dose methotrexate in rheumatoid arthritis: a potential risk factor for bisphosphonate-induced osteonecrosis of the jaw","volume":"22","author":"Mathai","year":"2018","journal-title":"Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.jormas.2022.03.012_bib0011","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/adj.12235","article-title":"Methotrexate-related lymphoproliferative disorder arising in the gingiva of a patient with rheumatoid arthritis","volume":"60","author":"Horie","year":"2015","journal-title":"Aust Dent J"},{"issue":"3","key":"10.1016\/j.jormas.2022.03.012_bib0012","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bjoms.2019.01.015","article-title":"Spontaneous bilateral osteonecrosis of the mandible in a bisphosphonate-naive patient","volume":"57","author":"Sklavos","year":"2019","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"9","key":"10.1016\/j.jormas.2022.03.012_bib0013","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.joen.2014.01.035","article-title":"Bisphosphonate-associated osteonecrosis of jaw reoccurrence after methotrexate therapy: a case report","volume":"40","author":"Alsalleeh","year":"2014","journal-title":"J Endodont"},{"issue":"5","key":"10.1016\/j.jormas.2022.03.012_bib0014","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ajoms.2018.03.005","article-title":"Osteonecrosis of the jaw with pancytopenia in a patient receiving methotrexate for reumathoid arthrirtis without antiresorptive or antianfiogenic agents: report of a case","volume":"30","author":"Sato","year":"2018","journal-title":"J Oral Maxillofacial Surg Med Pathol"},{"issue":"1","key":"10.1016\/j.jormas.2022.03.012_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.joms.2016.07.019","article-title":"Osteonecrosis of the jaw in the absence of antiresorptive or antiangiogenic exposure: a series of 6 cases","volume":"75","author":"Aghaloo","year":"2017","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jormas.2022.03.012_bib0016","first-page":"2","article-title":"American association of oral and maxillofacial surgeons","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.jormas.2022.03.012_bib0017","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.57.2.3","article-title":"Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis","volume":"57","author":"Cronstein","year":"2005","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.jormas.2022.03.012_bib0018","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bone.2008.09.014","article-title":"Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment","volume":"44","author":"Fan","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.jormas.2022.03.012_bib0019","article-title":"Methotrexate toxicity in growing long bones of young rats: a model for studying cancer chemotherapy-induced bone growth defects in children","volume":"2011","author":"Fan","year":"2011","journal-title":"J Biomed Biotechnol"},{"issue":"5","key":"10.1016\/j.jormas.2022.03.012_bib0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00005-015-0338-x","article-title":"Assessment of the effect of methotrexate therapy on bone metabolism in patients with rheumatoid arthritis","volume":"63","author":"\u015awierkot","year":"2015","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"2","key":"10.1016\/j.jormas.2022.03.012_bib0021","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11764-009-0083-4","article-title":"Skeletal sequelae of cancer and cancer treatment","volume":"3","author":"Stava","year":"2009","journal-title":"J Cancer Surviv Res Pract"},{"issue":"3","key":"10.1016\/j.jormas.2022.03.012_bib0022","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/jcp.21274","article-title":"Folinic acid attenuates methotrexate chemotherapy-induced damages on bone growth mechanisms and pools of bone marrow stromal cells","volume":"214","author":"Xian","year":"2008","journal-title":"J Cell Physiol"},{"issue":"9","key":"10.1016\/j.jormas.2022.03.012_bib0023","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/1097-0142(20011101)92:9<2419::AID-CNCR1591>3.0.CO;2-K","article-title":"High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia","volume":"92","author":"Banfi","year":"2001","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jormas.2022.03.012_bib0024","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/8756-3282(94)00032-U","article-title":"The short- and long-term effects of methotrexate on the rat skeleton","volume":"16","author":"Wheeler","year":"1995","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.jormas.2022.03.012_bib0025","first-page":"251","article-title":"Methotrexate (MTX) inhibits osteoblastic differentiation in vitro: possible mechanism of MTX osteopathy","volume":"28","author":"Uehara","year":"2001","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.jormas.2022.03.012_bib0026","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/ard.52.8.582","article-title":"Methotrexate osteopathy in rheumatic disease","volume":"52","author":"Preston","year":"1993","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jormas.2022.03.012_bib0027","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/archderm.1996.03890260086013","article-title":"Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis","volume":"132","author":"Zonneveld","year":"1996","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jormas.2022.03.012_bib0028","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jormas.2022.03.012_bib0029","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1746-160X-7-7","article-title":"Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports","volume":"7","author":"Conte-Neto","year":"2011","journal-title":"Head Face Med"},{"key":"10.1016\/j.jormas.2022.03.012_bib0030","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0002-9343(85)90057-9","article-title":"Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosis","volume":"79","author":"Zigic","year":"1985","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.jormas.2022.03.012_bib0031","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/BOR.0b013e32834518a3","article-title":"Pathophysiology of rheumatoid arthritis","volume":"23","author":"Cooles","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.jormas.2022.03.012_bib0032","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","article-title":"Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes","volume":"16","author":"Nygaard","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"10.1016\/j.jormas.2022.03.012_bib0033","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg"},{"issue":"5","key":"10.1016\/j.jormas.2022.03.012_bib0034","first-page":"e595","article-title":"Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents","volume":"21","author":"Rodriguez-Lozano","year":"2016","journal-title":"Med Oral Patol Oral Cirugia Bucal"},{"issue":"8","key":"10.1016\/j.jormas.2022.03.012_bib0035","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jcms.2017.05.027","article-title":"The impact of surgical intervention and antibiotics on MRONJ stage II and III - retrospective study","volume":"45","author":"Zirk","year":"2017","journal-title":"J Cranio-Maxillo-fac Surg Off Publ Eur Assoc Cranio-Maxillo-fac Surg"},{"issue":"3","key":"10.1016\/j.jormas.2022.03.012_bib0036","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3390\/ijerph18031018","article-title":"Treatment of stage 2 medication-induced osteonecrosis of the jaw: a case series","volume":"18","author":"Pardo-Zamora","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"10.1016\/j.jormas.2022.03.012_bib0037","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.amjoto.2006.08.004","article-title":"Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals","volume":"28","author":"Magopoulos","year":"2007","journal-title":"Am J Otolaryngol"},{"issue":"1","key":"10.1016\/j.jormas.2022.03.012_bib0038","first-page":"e141","article-title":"Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bisphosphonates","volume":"9","author":"Berm\u00fadez-Bejarano","year":"2017","journal-title":"J Clin Exp Dent"}],"container-title":["Journal of Stomatology, Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785522000593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785522000593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T10:14:59Z","timestamp":1762856099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468785522000593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2468785522000593"],"URL":"https:\/\/doi.org\/10.1016\/j.jormas.2022.03.012","relation":{},"ISSN":["2468-7855"],"issn-type":[{"value":"2468-7855","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible association of methotrexate use with osteonecrosis of the jaw: Systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Stomatology, Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jormas.2022.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}